Related Experiment Video
Updated: Jul 7, 2026
14:39
Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma
Published on: November 4, 2010
Treatment of mild persistent asthma
1Chair, Family Physician Airways Group of Canada.
Summary
For mild persistent asthma, specialists chose different treatment plans. Options included as-needed inhalers or daily medications, with evidence reviewed for each approach.
Area of Science:
- Pulmonology
- Allergy and Immunology
- Pharmacology
Background:
- Mild persistent asthma requires effective management strategies.
- Current treatment guidelines offer multiple therapeutic options.
- Individualized patient care is crucial for asthma control.
Purpose of the Study:
- To review evidence for different treatment options in mild persistent asthma.
- To analyze specialist preferences for asthma management.
- To compare the efficacy of various asthma medication regimens.
Main Methods:
- A typical case study of mild persistent asthma was presented.
- Three distinct treatment options were proposed to specialists.
- Respiratory specialists selected their preferred treatment approach.
- Recent research evidence supporting each option was reviewed.
Main Results:
- Each of the three respiratory specialists selected a different treatment option.
- Option 1: As-needed beclometasone/albuterol combination inhaler.
- Option 2: Daily oral leukotriene receptor antagonist plus as-needed short-acting beta2-agonist (SABA) inhaler.
- Option 3: Daily combination inhaled corticosteroid/long-acting beta2-agonist inhaler plus as-needed SABA.
Conclusions:
- Expert opinions vary on the optimal treatment for mild persistent asthma.
- Evidence-based review is essential for guiding treatment choices.
- Further research may clarify the most effective strategies for mild persistent asthma.
Related Concept Videos
01:30Asthma-IV: Diagnostic and Management
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
01:25Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
01:30Asthma-IV: Nursing Management
The nursing management of asthma is a comprehensive approach that relies heavily on the expertise and dedication of healthcare professionals. It involves thorough assessment, accurate diagnosis, strategic planning, effective implementation, and diligent evaluation. By meticulously following this step-by-step process, healthcare professionals play a crucial role in providing the best possible care and treatment for patients with asthma, enhancing their overall health and well-being.
First, in...
First, in...
01:26COPD: Management Using Bronchodilators and Corticosteroids
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
01:19Antiasthma Drugs: Leukotriene Modifiers
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
01:25Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...